Gary S Marshall

Summary

Affiliation: University of Louisville
Country: USA

Publications

  1. doi request reprint Rotavirus disease and prevention through vaccination
    Gary S Marshall
    Division of Pediatric Infectious Diseases, University of Louisville School of Medicine, Louisville, KY, USA
    Pediatr Infect Dis J 28:355-62, quiz 363-4. 2009
  2. ncbi request reprint Co-administration of a novel Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine does not interfere with the immune response to antigens contained in infant vaccines routinely used in the United Sta
    Gary S Marshall
    University of Louisville, Louisville, KY, USA
    Hum Vaccin 7:258-64. 2011
  3. ncbi request reprint Use of combination vaccines is associated with improved coverage rates
    Gary S Marshall
    Division of Pediatric Infectious Diseases, University of Louisville School of Medicine, Louisville, KY 40202, USA
    Pediatr Infect Dis J 26:496-500. 2007
  4. doi request reprint Immune response and one-year antibody persistence after a fourth dose of a novel Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine (HibMenCY) at 12 to 15 months of age
    Gary S Marshall
    Department of Pediatrics, University of Louisville School of Medicine, Louisville, KY 40202, USA
    Pediatr Infect Dis J 29:469-71. 2010
  5. ncbi request reprint Antibodies reactive to Rickettsia rickettsii among children living in the southeast and south central regions of the United States
    Gary S Marshall
    Department of Pediatrics, University of Louisville School of Medicine, Louisville, KY40202, USA
    Arch Pediatr Adolesc Med 157:443-8. 2003
  6. ncbi request reprint Clinical and laboratory features, hospital course, and outcome of Rocky Mountain spotted fever in children
    Steven C Buckingham
    Department of Pediatrics, University of Tennessee Health Science Center, Memphis, Tennessee, USA
    J Pediatr 150:180-4, 184.e1. 2007
  7. doi request reprint Immunogenicity and safety of H influenzae type b-N meningitidis C/Y conjugate vaccine in infants
    Kristina A Bryant
    University of Louisville, Louisville, Kentucky, USA
    Pediatrics 127:e1375-85. 2011
  8. doi request reprint Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y tetanus toxoid conjugate vaccine for infants and toddlers
    Kristina A Bryant
    Department of Pediatrics, University of Louisville School of Medicine, 571 South Floyd Street, Suite 321, Louisville, KY 40202, USA
    Expert Rev Vaccines 10:941-50. 2011
  9. ncbi request reprint Parental vaccine concerns in Kentucky
    Michael J Smith
    Division of Pediatric Infectious Diseases, University of Louisville School of Medicine, Louisville, KY, USA
    J Ky Med Assoc 107:342-9. 2009
  10. ncbi request reprint Cytomegalovirus seroprevalence among women of childbearing age during a 10-year period
    Gary S Marshall
    Department of Pediatrics, University of Louisville School of Medicine, Louisville, Kentucky 40202, USA
    Am J Perinatol 22:371-6. 2005

Collaborators

Detail Information

Publications18

  1. doi request reprint Rotavirus disease and prevention through vaccination
    Gary S Marshall
    Division of Pediatric Infectious Diseases, University of Louisville School of Medicine, Louisville, KY, USA
    Pediatr Infect Dis J 28:355-62, quiz 363-4. 2009
    ..The history of rotavirus vaccine development is also included, along with a discussion of the safety, efficacy, and recommended use of the approved vaccines...
  2. ncbi request reprint Co-administration of a novel Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine does not interfere with the immune response to antigens contained in infant vaccines routinely used in the United Sta
    Gary S Marshall
    University of Louisville, Louisville, KY, USA
    Hum Vaccin 7:258-64. 2011
    ..A schedule of HibMenCY-TT given concomitantly with PCV7 and DTaP-HepB-IPV would be expected to protect infants against all of the targeted diseases...
  3. ncbi request reprint Use of combination vaccines is associated with improved coverage rates
    Gary S Marshall
    Division of Pediatric Infectious Diseases, University of Louisville School of Medicine, Louisville, KY 40202, USA
    Pediatr Infect Dis J 26:496-500. 2007
    ..By reducing the number of injections, use of combination vaccines could lead to fewer deferred doses and improved coverage rates...
  4. doi request reprint Immune response and one-year antibody persistence after a fourth dose of a novel Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine (HibMenCY) at 12 to 15 months of age
    Gary S Marshall
    Department of Pediatrics, University of Louisville School of Medicine, Louisville, KY 40202, USA
    Pediatr Infect Dis J 29:469-71. 2010
    ..4%, respectively. One year later, anti-PRP concentrations > or =0.15 microg/mL, and MenC and MenY bactericidal titers > or =1:8 persisted in 100%, 96.6%, and 83.8%, respectively. The safety profile of HibMenCY was comparable to Hib...
  5. ncbi request reprint Antibodies reactive to Rickettsia rickettsii among children living in the southeast and south central regions of the United States
    Gary S Marshall
    Department of Pediatrics, University of Louisville School of Medicine, Louisville, KY40202, USA
    Arch Pediatr Adolesc Med 157:443-8. 2003
    ..This study estimated the prevalence of antibodies reactive to R rickettsii among children living in the southeastern and south central United States...
  6. ncbi request reprint Clinical and laboratory features, hospital course, and outcome of Rocky Mountain spotted fever in children
    Steven C Buckingham
    Department of Pediatrics, University of Tennessee Health Science Center, Memphis, Tennessee, USA
    J Pediatr 150:180-4, 184.e1. 2007
    ....
  7. doi request reprint Immunogenicity and safety of H influenzae type b-N meningitidis C/Y conjugate vaccine in infants
    Kristina A Bryant
    University of Louisville, Louisville, Kentucky, USA
    Pediatrics 127:e1375-85. 2011
    ..A phase III study evaluated the immunogenicity and safety of an investigational Haemophilus influenzae type b (Hib)-Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine (HibMenCY)...
  8. doi request reprint Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y tetanus toxoid conjugate vaccine for infants and toddlers
    Kristina A Bryant
    Department of Pediatrics, University of Louisville School of Medicine, 571 South Floyd Street, Suite 321, Louisville, KY 40202, USA
    Expert Rev Vaccines 10:941-50. 2011
    ..If licensed, HibMenCY-TT not only represents an incremental option for protection against invasive Hib, but also has the potential to prevent invasive meningococcal disease without increasing the number of injections...
  9. ncbi request reprint Parental vaccine concerns in Kentucky
    Michael J Smith
    Division of Pediatric Infectious Diseases, University of Louisville School of Medicine, Louisville, KY, USA
    J Ky Med Assoc 107:342-9. 2009
    ..Locally produced vaccine risk communication materials may be effective in reassuring these parents. However, little is known about specific vaccine safety concerns in the state of Kentucky...
  10. ncbi request reprint Cytomegalovirus seroprevalence among women of childbearing age during a 10-year period
    Gary S Marshall
    Department of Pediatrics, University of Louisville School of Medicine, Louisville, Kentucky 40202, USA
    Am J Perinatol 22:371-6. 2005
    ..Such women born after 1975 may be more likely to reach the childbearing years with CMV immunity as compared with women born before then...
  11. doi request reprint Antibody persistence for up to 5 years after a fourth dose of Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine (HibMenCY-TT) given at 12-15 months of age
    Gary S Marshall
    University of Louisville School of Medicine, Louisville, KY 40202, USA
    Pediatr Infect Dis J 32:662-8. 2013
    ..This study assessed antibody persistence up to 5 years after vaccination...
  12. ncbi request reprint Clinical and epidemiological aspects of rotavirus infection
    Matt Zahn
    Division of Pediatric Infectious Diseases, University of Louisville School of Medicne, KY 40202, USA
    Pediatr Ann 35:23-8. 2006
    ..Vaccination is the only practical way to gain control over rotavirus disease. Prevention through the universal use of improved live oral vaccines is on the horizon...
  13. ncbi request reprint Rocky Mountain spotted fever at Koair Children's Hospital, 1990-2002
    Amy M Hayden
    Department of Pediatrics, University of Louisville School of Medicine, Louisville, Kentucky, USA
    J Ky Med Assoc 102:209-14. 2004
    ..Initial clinical features may be nonspecific. This, as well as decreased awareness of disease and (unjustified) reluctance to use doxycycline may contribute to delays in initiating therapy...
  14. doi request reprint Common variable immunodeficiency presenting with persistent parvovirus B19 infection
    Sarah T M Adams
    Department of Pediatrics, University of Louisville School of Medicine, Louisville, Kentucky, Louisville, KY 40202, USA
    Pediatrics 130:e1711-5. 2012
    ..This case demonstrates that persistent parvovirus infection may be a presenting feature of humoral immune deficiency and can mimic juvenile rheumatoid arthritis. The infection may respond to immune globulin intravenous therapy...
  15. doi request reprint Use of standardized patients to examine physicians' communication strategies when addressing vaccine refusal: a pilot study
    Kristina A Bryant
    Department of Pediatrics, University of Louisville, Louisville, KY, United States
    Vaccine 27:3616-9. 2009
    ..The median recorded encounter lasted 19 min. SMs represent a novel strategy for studying physician/parent communication about vaccines...
  16. ncbi request reprint One for all: newer combination vaccines in practice
    Gary S Marshall
    Department of Pediatrics, University of Louisville School of Medicine, Louisville, KY, USA
    Pediatr Ann 33:501-11. 2004
    ..In addition, there's the pentavalent bovine reassortant rotavirus vaccine (Rotateq) which, although given orally, will further crowd the schedule. The sooner we become comfortable with combination vaccines, the better...
  17. ncbi request reprint Ehrlichia chaffeensis seroprevalence among children in the southeast and south-central regions of the United States
    Gary S Marshall
    Division of Pediatric Infectious Diseases, University of Louisville School of Medicine, 571 S Floyd St, Suite 321, Louisville, KY 40202, USA
    Arch Pediatr Adolesc Med 156:166-70. 2002
    ..The reported annual incidence of human monocytic ehrlichiosis, which is due to infection with Ehrlichia chaffeensis, is as high as 5.5 per million in some states, but serosurveys suggest much higher infection rates in some populations...
  18. ncbi request reprint Epidemiology of methicillin-resistant Staphylococcus aureus at a children's hospital
    Andrew L Campbell
    Kosair Children s Hospital, University of Louisville, Louisville, Kentucky 40204, USA
    Infect Control Hosp Epidemiol 24:427-30. 2003
    ..To describe the relative contribution of and risk factors for both community-acquired and nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infections...